BioNexus Gene Lab Corp. (BGLC)
USD 0.26
(-2.99%)
USD 0.26
(-2.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.3 Million | 544.02 Thousand | 9161.00 | 552.68 Thousand | -217.27 Thousand | -274.08 Thousand |
| Net Income | -2.62 Million | -355.96 Thousand | 751.57 Thousand | 1.09 Million | -246.46 Thousand | 26.45 Thousand |
| Depreciation & Amortization | 108.42 Thousand | 105.41 Thousand | 108.21 Thousand | 101.6 Thousand | 53.33 Thousand | 40.61 Thousand |
| Deferred income taxes | 160.38 Thousand | - | - | - | - | - |
| Stock-based compensation | 511.74 Thousand | - | - | - | - | - |
| Change in working capital | 117.97 Thousand | 833.38 Thousand | -862.24 Thousand | 102.36 Thousand | -24.13 Thousand | -341.14 Thousand |
| Other non-cash items | 428.91 Thousand | -38.81 Thousand | 11.62 Thousand | -745.38 Thousand | 129.54 Thousand | 528.04 Thousand |
| Investing Cash Flow | -382.57 Thousand | -450.49 Thousand | -490.57 Thousand | 1.31 Million | -12.81 Thousand | -51.7 Thousand |
| Investments in PPE | -149.39 Thousand | -54.17 Thousand | -3162.00 | -421.62 Thousand | -12.81 Thousand | -39.62 Thousand |
| Acquisitions | 470.13 Thousand | - | - | 346 Thousand | - | - |
| Investment purchases | -320.73 Thousand | -511.7 Thousand | -515.84 Thousand | -108.63 Thousand | - | -12.08 Thousand |
| Sales/Maturities of investments | 26.14 Thousand | - | 6392.00 | 30.05 Thousand | - | - |
| Other Investing Activities | -408.72 Thousand | 115.37 Thousand | 22.03 Thousand | 1.47 Million | -12.81 Thousand | -12.08 Thousand |
| Financing Cash Flow | 5.75 Million | 115.96 Thousand | -28.22 Thousand | -4947.00 | -180.8 Thousand | 742.94 Thousand |
| Debt repayment | - | -34.03 Thousand | -26.3 Thousand | -4947.00 | -16.77 Thousand | - |
| Dividends payments | -61.4 Thousand | -115.37 Thousand | -22.03 Thousand | -6310.00 | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.75 Million | 150 Thousand | - | - | - | 741.5 Thousand |
| Other Financing Activities | 5.75 Million | 0.12 | 20.11 Thousand | 6310.00 | -164.02 Thousand | 742.94 Thousand |
| Accounts receivables | 650.81 Thousand | 538.64 Thousand | 579.21 Thousand | 411.06 Thousand | 9758.00 | 105.67 Thousand |
| Accounts payables | -349.32 Thousand | -119.69 Thousand | -1.13 Million | -524.24 Thousand | -30.6 Thousand | -463.6 Thousand |
| Inventory | -160.38 Thousand | 544.1 Thousand | -345.74 Thousand | 147.03 Thousand | 7721.00 | 16.78 Thousand |
| Other working capital | -23.12 Thousand | -129.67 Thousand | 39.97 Thousand | 68.49 Thousand | -11.01 Thousand | -357.93 Thousand |
| Cash at beginning of period | 2.11 Million | 2.12 Million | 2.78 Million | 859.07 Thousand | 1.26 Million | 839.14 Thousand |
| Cash at end of period | 5.92 Million | 2.11 Million | 2.12 Million | 2.78 Million | 859.07 Thousand | 1.26 Million |
| Capital Expenditure | -149.39 Thousand | -54.17 Thousand | -3162.00 | -421.62 Thousand | -12.81 Thousand | -39.62 Thousand |
| Effect of forex changes on cash | -259.67 Thousand | -214.54 Thousand | -154.13 Thousand | 60.89 Thousand | 9732.00 | 3933.00 |
| Net cash flow / Change in cash | 3.81 Million | -5055.00 | -663.77 Thousand | 1.92 Million | -401.16 Thousand | 421.09 Thousand |
| Free Cash Flow | -1.45 Million | 489.85 Thousand | 5999.00 | 131.05 Thousand | -230.09 Thousand | -313.7 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 199.1 Thousand | -103.75 Thousand | -2.62 Million | 307.41 Thousand | -2.6 Million | -259.25 Thousand |
| Depreciation & Amortization | 31.45 Thousand | 29.58 Thousand | 108.42 Thousand | 29.65 Thousand | 29.28 Thousand | 24.6 Thousand |
| Deferred income taxes | - | - | 160.38 Thousand | -524.55 Thousand | - | - |
| Stock-based compensation | - | - | 511.74 Thousand | -88.95 Thousand | - | - |
| Change in working capital | -326.33 Thousand | 3916.00 | 117.97 Thousand | 12.44 Thousand | 106.63 Thousand | 26.9 Thousand |
| Other non-cash items | -185.34 Thousand | 90.84 Thousand | 428.91 Thousand | 2083.00 | 1.57 Million | 185.69 Thousand |
| Investing Cash Flow | 71.18 Thousand | 15.15 Thousand | -382.57 Thousand | -13.75 Thousand | -360.71 Thousand | -3058.00 |
| Investments in PPE | -1833.00 | -21.94 Thousand | -149.39 Thousand | -937.00 | -134 Thousand | -14.35 Thousand |
| Acquisitions | - | - | 470.13 Thousand | 26.85 Thousand | -26.85 Thousand | - |
| Investment purchases | -90.52 Thousand | -174.24 Thousand | -320.73 Thousand | -24.62 Thousand | -282.66 Thousand | 202.00 |
| Sales/Maturities of investments | 86.33 Thousand | 211.34 Thousand | 26.14 Thousand | -708.00 | 26.85 Thousand | - |
| Other Investing Activities | 77.2 Thousand | -187.24 Thousand | -408.72 Thousand | 12.51 Thousand | 55.95 Thousand | 11.09 Thousand |
| Financing Cash Flow | 175.41 Thousand | 26.93 Thousand | 5.75 Million | 11.11 Thousand | 5.74 Million | -4212.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | -8946.00 | -61.4 Thousand | -61.4 Thousand | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 5.75 Million | -5.75 Million | 5.75 Million | - |
| Other Financing Activities | 175.41 Thousand | 26.93 Thousand | 5.75 Million | 11.11 Thousand | 5.74 Million | -4212.00 |
| Accounts receivables | 153.23 Thousand | -105.66 Thousand | 650.81 Thousand | 145.14 Thousand | 151.37 Thousand | 18.77 Thousand |
| Accounts payables | -513.65 Thousand | 55.22 Thousand | -349.32 Thousand | -94.59 Thousand | -103.32 Thousand | 282.49 Thousand |
| Inventory | 43.95 Thousand | 60.81 Thousand | -160.38 Thousand | -29.88 Thousand | 57.46 Thousand | -266.13 Thousand |
| Other working capital | -9866.00 | -6463.00 | -23.12 Thousand | -8218.00 | 1124.00 | -8228.00 |
| Cash at beginning of period | 5.83 Million | 5.92 Million | 2.11 Million | 6.14 Million | 1.75 Million | 1.97 Million |
| Cash at end of period | 5.41 Million | 5.83 Million | 5.92 Million | 5.92 Million | 6.14 Million | 1.75 Million |
| Capital Expenditure | -1833.00 | -21.94 Thousand | -149.39 Thousand | -937.00 | -134 Thousand | -14.35 Thousand |
| Effect of forex changes on cash | -4250.00 | -111.03 Thousand | -259.67 Thousand | 46.99 Thousand | -99.16 Thousand | -185.21 Thousand |
| Net cash flow / Change in cash | -418.14 Thousand | -97.15 Thousand | 3.81 Million | -217.54 Thousand | 4.38 Million | -214.53 Thousand |
| Free Cash Flow | -662.32 Thousand | -50.15 Thousand | -1.45 Million | -262.84 Thousand | -1.03 Million | -36.4 Thousand |
WPP
ETCMY
WARN
7711
NLOP
ALMIL